CoChat

Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet/streptozotocin-induced diabetic rat

Al-Trad, Bahaa, Alkhateeb, Hakam, Alsmadi, Wesam, Al-Zoubi, Mazhar · 2019 · Life Sciences
Cited by 125

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Eugenol, a phenolic compound present in many plant essential oils, demonstrated anti‐diabetic activity but the underlying mechanisms are not fully understood. The aim of the present study was to examine the anti‐diabetic, anti‐oxidative and the anti‐inflammatory effect of eugenol in high‐fat‐diet (HFD) and streptozotocin (STZ)‐induced diabetic rats. Additionally, the effect of eugenol on the insulin sensitivity and on skeletal muscle protein contents of glucose transporter‐4 (GLUT4) and AMP‐activated protein kinase (AMPK) was investigated. Materials and methods: HFD/STZ‐induced diabetic rats were treated orally with eugenol (10mg/kg) for 45days. After the end of the experiment, blood and skeletal muscle samples were collected. Metformin was used as positive control. Results: The anti‐diabetic effects of eugenol were demonstrated by the significant reduction in the levels of serum glucose, triglyceride, cholesterol, Low‐density lipoprotein, malondialdehyde and interleukin‐6 in the treated group compared to the diabetic group. Additionally, eugenol treatment significantly restored the decreased serum levels of insulin and glutathione when compared to that of the diabetic control rats. The homeostasis model assessment of insulin resistance (HOMA‐IR) was significantly lower in rats treated with eugenol than in the diabetic rats. The skeletal muscle protein contents of GLUT4 and AMPK were higher in the eugenol treated group than in the diabetic control group. Conclusion: Eugenol possesses potent anti‐oxidative and anti‐inflammatory effect in HFD/STZ‐induced diabetic rats. Moreover, eugenol facilitates insulin sensitivity and stimulate skeletal muscle glucose uptake via activation of the GLUT4‐AMPK signaling pathway. Eugenol could represent a promising therapeutic agent to prevent type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.lfs.2018.11.034

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Al-Trad, B., Alkhateeb, H., Alsmadi, W., & Al-Zoubi, M.
Venue
Life Sciences
Publisher
Elsevier BV
Published
2019-01
Volume
216
Pages
183-188
ISSN
0024-3205 (ISSN-L)
OpenAlex
W2901508016
Cited by
125
References
7
FWCI
6.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.